It is noteworthy that the 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of SCD, while mentioning the increased risk of patients with LMNA, FLNC, PLN, and RBM20 variants in their recommendations, do not include any consideration regarding DSP variant carriers [31]. This evidence concerns the gene DSP and Schnyder corneal dystrophy.